Go to content
Attention:

Lukt het niet om in te loggen op het AFM Portaal?

Het kan helpen om uw browsergeschiedenis/cookies te verwijderen

Crucell N.V.

Crucell N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 12 aug 2008 - 12:33
Statutaire naam Crucell N.V.
Titel Crucell Announces Second Quarter 2008 Results
Bericht Total revenue and other operating income increased by 51% to €59.6 million, compared to €39.4 million in the second quarter of 2007. Solid gross margins of 36% and significantly reduced net loss for the second quarter to €7.9 million compared to €18.2 million in Q207. 2008 full year guidance reiterated: total revenue and other operating income growth of 20% in constant currencies[1]; higher margins; positive cash flow. Leiden, The Netherlands (August 12, 2008) - Dutch biopharma company Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) today announced its financial results for the second quarter of 2008, based on International Financial Reporting Standards (IFRS). These financial results are unaudited.